Why the study?
Does preoperative atrial fibrillation increase the risk of short- and long-term mortality in patients undergoing aortic valve replacement?
Does preoperative atrial fibrillation increase the risk of short- and long-term mortality in patients undergoing aortic valve replacement?
Preoperative atrial fibrillation is a significant risk factor for both early and late mortality following aortic valve replacement, suggesting a potential benefit for concomitant AF ablation.
Answers are grounded in this paper and cite their sources.
Identifies preoperative AF as a high-risk marker in aortic valve replacement; leaves open.
INTRODUCTION: This systematic review and meta-analysis was performed to evaluate the impact of preoperative atrial fibrillation (preAF) on early and late outcomes after aortic valve replacement (AVR). EVIDENCE ACQUISITION: Medline, EMBASE, and CENTRAL were systematically searched for studies that reported AVR outcomes according to the presence or absence of preAF. Data were independently extracted by two investigators; a meta-analysis was conducted according to predefined clinical endpoints. Studies including patients undergoing concomitant atrial fibrillation surgery were excluded. EVIDENCE SYNTHESIS: Six observational studies with 8 distinct AVR cohorts (AVR± concomitant surgery) met criteria for inclusion, including a total of 6693 patients. Of these, 1014 (15%) presented with preAF. Overall, perioperative mortality was increased in patients with preAF (odds ratio [OR] 2.33; 95% CI: 1.48-3.67; P<0.001). Subgroup analysis of patients undergoing isolated AVR also demonstrated preAF as a risk factor for perioperative mortality (OR 2.49; 95% CI: 1.57-3.95; P<0.001). PreAF was also associated with acute renal failure (OR 1.42; 95% CI: 1.07-1.89; P=0.02) but not stroke (OR 1.11; 95% CI: 0.59-2.12; P=0.74). Late mortality was significantly higher in patients with preAF (hazard ratio [HR] 1.75; 95% CI: 1.33-2.30; P<0.001). This relationship remained true when only patients who underwent isolated AVR were analyzed (HR 1.97; 95% CI: 1.11-3.51; P=0.02). CONCLUSIONS: PreAF is associated with an increased risk of early- and late-mortality after AVR. These data support the more widespread utilization of concomitant AF ablation.
No takes yet. Share an insight, caveat, or question.
Saxena et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: